News

2020

COVID-19 risks turning back the clock on years of essential development work

Barriers and facilitators of access to Internationally Controlled Essential Medicines in Kenya

HAI Releases Annual Report 2019

Clinical trials and COVID-19

Reflections on the World Health Assembly

COVID-19 And Its Far-Reaching Health Impacts in Sub-Saharan Africa

Why TRIPS flexibilities are a crucial mechanism for access to medicines

EU Must Not Miss its Chance on WHO Technology Pool

TRIPS-flexibilities in Health Crises and Beyond

In defence of WHO

The hidden impact of COVID-19 on sexual and reproductive health

Community measures to prevent snakebite during COVID-19

Reversed gains in the advancement of SRHR in Kenya; effects of COVID-19

To tackle COVID-19 pandemic, transparency and collaboration are vital

COVID-19, social determinants and frontline workers

Health Action International Working from Home

Ensure transparency, affordability and availability of vaccines and treatments for COVID-19, say MEPs

HAI Follows Dutch Government Advice in Response to COVID-19

HAI Recognised for Commitment to Gender Equality

Europe’s Beating Cancer Plan

Niets magisch aan medicijnprijzen

Nothing magical about medicine prices

US puts pressure on the Netherlands over compulsory licenses

A busy week at the Court of Justice of the European Union

2019

How to measure change in EU Policy

Health Technology Assessments: will 2020 end the deadlock?

Is clinical trial transparency under threat?

Statement from the ACCISS Study regarding the WHO announcement of the first-ever insulin prequalification programme

REBRAND: Fact or Fiction publication

An insightful day at the EURIPID stakeholder meeting in Budapest